Literature DB >> 33176625

Clinical features of and risk factors for intracranial aneurysms associated with moyamoya disease.

Hecheng Yang1, Limin Zhang1, Menghan Wang1, Jingtao Wang1, Lijie Chen1, Hong Lu1.   

Abstract

BACKGROUND: The clinical features of aneurysms associated with moyamoya disease (MMD) and risk factors for the formation and rupture of aneurysms are not well defined. AIMS: In this study, we retrospectively analyzed clinical data of MMD patients and examined the potential risk factors for the formation and rupture of aneurysms in these patients.
METHODS: The medical records of all MMD patients in our hospital from April 2012 to May 2019 were reviewed. The logistic regression analysis was used to determine the independent association between various potential risk factors and the presence or rupture of intracranial aneurysms in MMD patients.
RESULTS: Of 2230 MMD patients, 182 (8.2%) cases had intracranial aneurysms. The mean age of onset in patients with aneurysms was 47.2 years, which was significantly higher when compared with those without aneurysms (p < 0.001). In logistic regression analysis, age of onset remained significantly associated with the presence of intracranial aneurysms, while female gender, hypertension, diabetes mellitus, and coronary artery disease were not. Besides, intracranial aneurysms were significantly associated with intracranial hemorrhage in MMD patients (odds ratio [OR] = 5.19; 95% confidence interval [CI], 3.80-7.09). About 60% aneurysms >5 mm in size, and 62.1% aneurysms with irregularly shaped morphology were ruptured. Aneurysms located in basilar tip, collateral or moyamoya vessels were more likely to present with rupture.
CONCLUSIONS: Age was an important risk factor for intracranial aneurysms formation in MMD patients. Aneurysms increased the risk of intracerebral hemorrhage in MMD patients, and their ruptures were correlated with aneurysms size, location, and morphology.

Entities:  

Keywords:  Cerebrovascular disease; intracranial aneurysms; moyamoya disease; risk factor

Year:  2020        PMID: 33176625     DOI: 10.1177/1747493020967224

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  3 in total

Review 1.  Aspirin Therapy in Cardiovascular Disease with Glucose-6-Phosphate Dehydrogenase Deficiency, Safe or Not?

Authors:  Jianle Li; Yicong Chen; Zilin Ou; Fubing Ouyang; Jiahui Liang; Zimu Jiang; Chunyong Chen; Pingping Li; Jiaxin Chen; Jiating Wei; Jinsheng Zeng
Journal:  Am J Cardiovasc Drugs       Date:  2020-12-14       Impact factor: 3.571

2.  Development and Validation of a Nomogram to Predict the Individual Future Stroke Risk for Adult Patients With Moyamoya Disease: A Multicenter Retrospective Cohort Study in China.

Authors:  Fei Ye; Tianzhu Wang; Haoyuan Yin; Jiaoxing Li; Haiyan Li; Tongli Guo; Xiong Zhang; Tingting Yang; Liang Jie; Xiaoxin Wu; Qi Li; Wenli Sheng
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

3.  Long-Lasting Unruptured Large Intracranial Aneurysm in Bilateral Moyamoya Disease: Case Report.

Authors:  Eunyoung Chae; Soomin Jeong; Chan-Hyuk Lee
Journal:  Case Rep Neurol Med       Date:  2022-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.